Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis - ScienceDirect
IL-23 Inhibitors for Psoriasis Therapeutic Cheat Sheet - Next Steps in Dermatology
Neuer IL-23-Antikörper bei Psoriasis | PZ – Pharmazeutische Zeitung
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? | Annals of the Rheumatic Diseases
IL-23 in inflammatory bowel diseases and colon cancer - ScienceDirect
Interleukin-17 and Interleukin-23: A Narrative Review of Mechanisms of Action in Psoriasis and Associated Comorbidities | SpringerLink
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation? | Annals of the Rheumatic Diseases
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting | Nature Reviews Gastroenterology & Hepatology
Ustekinumab, a human monoclonal antibody, works by inhibiting the... | Download Scientific Diagram
Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy? - Ergen - 2018 - Experimental Dermatology - Wiley Online Library
Frontiers | Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis
Paradoxical gastrointestinal effects of interleukin-17 blockers | Annals of the Rheumatic Diseases
Psoriasistherapie mit IL-17- und IL-23-Blockern – Rosenfluh.ch
Frontiers | The Interleukin-23/Interleukin-17 Axis Links Adaptive and Innate Immunity in Psoriasis
Cells | Free Full-Text | Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
Frontiers | Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
Schematic representation of IL-12 and IL-23 with their receptors and... | Download Scientific Diagram
IL-23 Antagonists in the Treatment of Plaque Psoriasis - Dermatology Advisor
IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting | Nature Reviews Gastroenterology & Hepatology
Hoch effektiv gegen Entzündungen | PZ – Pharmazeutische Zeitung
Cells | Free Full-Text | Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment - ten Bergen - 2020 - Scandinavian Journal of Immunology - Wiley Online Library
New anti-IL-23 drugs raise hopes for psoriasis plaque clearance | Nature Biotechnology
Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on Risankizumab | SpringerLink
Inhibition of interleukin‐12 and/or interleukin‐23 for the treatment of psoriasis: What is the evidence for an effect on malignancy? - Ergen - 2018 - Experimental Dermatology - Wiley Online Library
Cells | Free Full-Text | Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
Plaque-Psoriasis: Erster reiner IL-23-Blocker zur Psoriasis-Therapie verfügbar